The first intermediate substrate in the heme synthetic pathway, 5-aminolevulinic acid (ALA), is neurotoxic in animal models and may be responsible for some of the adverse neurologic outcomes in lead poisoning and porphyria in adult humans. ALA is a substrate for the enzyme aminolevulinic acid dehydr
Degradation mechanism and stability of 5-aminolevulinic acid
β Scribed by A. Bunke; O. Zerbe; H. Schmid; G. Burmeister; H. P. Merkle; B. Gander
- Publisher
- John Wiley and Sons
- Year
- 2000
- Tongue
- English
- Weight
- 212 KB
- Volume
- 89
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Photodynamic (PDT) therapy is a relatively new technique with unique properties that make it attractive for the local treatment of superficial epithelial disorders. The objective of this study was to investigate the clinical response of PDT with the photosensitizing agent 5-aminolevulinic acid (5-AL
Polycyanoacrylates were found to be inherently unstable. Even in the absence of a deliberately added strong base, their molecular weights decreased drastically on standing in solution in accord with observations by Ryan and McCann (Makromol Chem Rapid Commun 1996, 17, 217). The initial high molecula
## Abstract Poor skin permeability limits the application of peptides to the skin. Enhanced skin permeation could facilitate the development of new therapies for dermatologic and cosmeceutical applications. The aim of this study was to investigate the application of iontophoresis to the delivery of
Protoporphyrin IX (Pp IX) is the main photosensitizer in photochemotherapy with 5-aminolevulinic acid (ALA). Pp IX is photolabile and the present work shows that 70-95% of Pp IX in cells is degraded by clinically relevant light exposures (40-200 J cm 22 at 630 nm). During light exposure a small yiel
diagnosis was conducted. Norway. ## RESULTS. Several individual studies in which patients with primary nonmelanoma cutaneous tumors received topical ALA-based PDT have reported promising re-